Medical Device Network on MSN
FDA classifies J&J MedTech’s CEREPAK recall as Class I following patient death
A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...
The FDA issued a notice to label a recall of Johnson & Johnson MedTech's Cerenovus unit's detachable coils as its most ...
Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...
In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)’s stock experienced a remarkable ...
Johnson & Johnson (NYSE:JNJ) is one of the best long term low volatility stocks to invest in. On January 30, BofA lifted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results